Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A comprehensive review of the FDA-approved labels of diabetes drugs: Indications, safety, and emerging cardiovascular safety data
Evgenia Gourgari, Erin E. Wilhelm, Hamid Hassanzadeh, et al.
Journal of Diabetes and its Complications (2017) Vol. 31, Iss. 12, pp. 1719-1727
Open Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

Gut Microbiota and Complications of Type-2 Diabetes
Camelia Oana Iatcu, Aimee Steen, Mihai Covașă
Nutrients (2021) Vol. 14, Iss. 1, pp. 166-166
Open Access | Times Cited: 267
Treatment strategies against diabetes: Success so far and challenges ahead
Rubiya Khursheed, Sachin Kumar Singh, Sheetu Wadhwa, et al.
European Journal of Pharmacology (2019) Vol. 862, pp. 172625-172625
Closed Access | Times Cited: 183
Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales
Amelia D. Dahlén, Giovanna Dashi, Ivan Maslov, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 177
Design and discovery of boronic acid drugs
Jessica Plescia, Nicolas Moitessier
European Journal of Medicinal Chemistry (2020) Vol. 195, pp. 112270-112270
Open Access | Times Cited: 154
GLP-1 agonists: A review for emergency clinicians
Brit Long, Jessica Pelletier, Alex Koyfman, et al.
The American Journal of Emergency Medicine (2024) Vol. 78, pp. 89-94
Closed Access | Times Cited: 24
Considerations when using alpha-glucosidase inhibitors in the treatment of type 2 diabetes
Maka S. Hedrington, Stephen N. Davis
Expert Opinion on Pharmacotherapy (2019) Vol. 20, Iss. 18, pp. 2229-2235
Closed Access | Times Cited: 132
Evaluation of the Anti-Diabetic Activity of Some Common Herbs and Spices: Providing New Insights with Inverse Virtual Screening
Andreia S.P. Pereira, Antonio Jesús Banegas‐Luna, Jorge Peña‐García, et al.
Molecules (2019) Vol. 24, Iss. 22, pp. 4030-4030
Open Access | Times Cited: 92
Medicinal Plants with Multiple Effects on Diabetes Mellitus and Its Complications: a Systematic Review
Zeinab Nazarian-Samani, Robert D. E. Sewell, Zahra Lorigooini, et al.
Current Diabetes Reports (2018) Vol. 18, Iss. 10
Closed Access | Times Cited: 84
Cost Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors, Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists, and Dipeptidyl Peptidase-4 (DPP-4) Inhibitors: A Systematic Review
Dongzhe Hong, Lei Si, Minghuan Jiang, et al.
PharmacoEconomics (2019)
Closed Access | Times Cited: 62
Impact of ENHANCED (diEtitiaNs Helping pAtieNts CarE for Diabetes) Telemedicine Randomized Controlled Trial on Diabetes Optimal Care Outcomes in Patients with Type 2 Diabetes
Gretchen Benson, Abbey Sidebottom, Joy Hayes, et al.
Journal of the Academy of Nutrition and Dietetics (2019) Vol. 119, Iss. 4, pp. 585-598
Closed Access | Times Cited: 57
Characteristics of Food Protein-Derived Antidiabetic Bioactive Peptides: A Literature Update
Nhung Thi Phuong Nong, Jue‐Liang Hsu
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9508-9508
Open Access | Times Cited: 45
An overview on small molecule-induced differentiation of mesenchymal stem cells into beta cells for diabetic therapy
Nimshitha Pavathuparambil Abdul Manaph, Kisha N. Sivanathan, Jodie Nitschke, et al.
Stem Cell Research & Therapy (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 46
Potential Role of Phytochemicals as Glucagon-like Peptide 1 Receptor (GLP-1R) Agonists in the Treatment of Diabetes Mellitus
J. O. Abiola, Ayoola Abidemi Oluyemi, Olajumoke Tolulope Idowu, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 736-736
Open Access | Times Cited: 5
Activity and selectivity cliffs for DPP‐IV inhibitors: Lessons we can learn from SAR studies and their application to virtual screening
María José Ojeda, Aleix Gimeno, Sarah Tomas‐Hernández, et al.
Medicinal Research Reviews (2018) Vol. 38, Iss. 6, pp. 1874-1915
Closed Access | Times Cited: 41
Novel glitazones as PPARγ agonists: molecular design, synthesis, glucose uptake activity and 3D QSAR studies
Subhankar P. Mandal, Aakriti Garg, P. Prabitha, et al.
Chemistry Central Journal (2018) Vol. 12, Iss. 1
Open Access | Times Cited: 41
Exploring African Medicinal Plants for Potential Anti-Diabetic Compounds with the DIA-DB Inverse Virtual Screening Web Server
Andreia S.P. Pereira, Helena den-Haan, Jorge Peña‐García, et al.
Molecules (2019) Vol. 24, Iss. 10, pp. 2002-2002
Open Access | Times Cited: 38
Bioactive Peptides: An Understanding from Current Screening Methodology
Nhung Thi Phuong Nong, Jue‐Liang Hsu
Processes (2022) Vol. 10, Iss. 6, pp. 1114-1114
Open Access | Times Cited: 22
Recent Advances in the Synthesis and Medicinal Perspective of Pyrazole-Based α-Amylase Inhibitors as Antidiabetic Agents
Rakesh Khator, Vikramdeep Monga
Future Medicinal Chemistry (2024) Vol. 16, Iss. 2, pp. 173-195
Closed Access | Times Cited: 4
CURRENT PERSPECTIVES ON USING NANOPARTICLES FOR DIABETES MANAGEMENT
NITESH KUMAR YADAV, Rupa Mazumder, Anjna Rani, et al.
International Journal of Applied Pharmaceutics (2024), pp. 38-45
Open Access | Times Cited: 4
Risk of Esophageal and Gastric Cancer in Patients with Type 2 Diabetes Receiving Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAs): A National Analysis
Mark Ayoub, Rafi Aibani, Tiana Dodd, et al.
Cancers (2024) Vol. 16, Iss. 18, pp. 3224-3224
Open Access | Times Cited: 4
Plant-Derived Flavonoids as AMPK Activators: Unveiling Their Potential in Type 2 Diabetes Management through Mechanistic Insights, Docking Studies, and Pharmacokinetics
Dong Oh Moon
Applied Sciences (2024) Vol. 14, Iss. 19, pp. 8607-8607
Open Access | Times Cited: 4
Emerging role of GLP-1 agonists in cardio-metabolic therapy - Focus on Semaglutide
Celestine I. Odigwe, Rajasekhar Mulyala, H. A. Malik, et al.
American Heart Journal Plus Cardiology Research and Practice (2025) Vol. 52, pp. 100518-100518
Open Access
Xiexin Tang restores gut barrier function by regulating the differentiation of CD4 + T cells via GPRs and HDACs in T2DM rats
Meijuan Liu, Yun Zhang, Ke Zhu, et al.
Journal of Asian Natural Products Research (2025), pp. 1-15
Closed Access
National trends in per-capita medical expenditures among U.S. adults with diabetes, 2000–2022
Shichao Tang, Yu Wang, Xilin Zhou, et al.
Diabetes Research and Clinical Practice (2025), pp. 112154-112154
Closed Access
Current Progress in Pharmacogenetics of Second-Line Antidiabetic Medications: Towards Precision Medicine for Type 2 Diabetes
Chan Uk Heo, Chang‐Ik Choi
Journal of Clinical Medicine (2019) Vol. 8, Iss. 3, pp. 393-393
Open Access | Times Cited: 32
Page 1 - Next Page

Scroll to top